The effect of 8-week different-intensity walking exercises on serum hepcidin, IL-6, and iron metabolism in pre-menopausal women.
Study Goal
The researchers aimed to examine the chronic effects of two different-intensity walking exercises on hepcidin, interleukin 6 (IL-6), and markers of iron metabolism in premenopausal women.
Results Summary
The study compared moderate tempo walking and brisk walking over 8 weeks, finding that both exercise groups showed changes in hepcidin and iron metabolism markers, though specific outcomes were not detailed in the abstract.
Population
Premenopausal women
Effective Dosage
3 days/week, starting from 30 to 51 minutes per session (moderate tempo walking at ~50-55% HRR, brisk walking at ~70-75% HRR)
Duration
8 weeks
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
moderate tempo walking group (MTWG) | neutral | hepcidin, interleukin 6 (IL-6), and markers of iron metabolism | pre-menopausal women | - | chronic effects of | #1 |
brisk walking group (BWG) | neutral | hepcidin, interleukin 6 (IL-6), and markers of iron metabolism | pre-menopausal women | - | chronic effects of | #2 |
Objective Hepcidin may be an important mediator in exercise-induced iron deficiency. Despite the studies investigating acute exercise effects on hepcidin and markers of iron metabolism, we found no studies examining the chronic effects of walking exercises (WE) on hepcidin and markers of iron metabolism in premenopausal women. The chronic effects of two 8-week different-intensity WE on hepcidin, interleukin 6 (IL-6), and markers of iron metabolism in pre-menopausal women were examined. Methods Exercise groups (EG) [moderate tempo walking group (MTWG), n = 11; brisk walking group (BWG), n = 11] walked 3 days/week, starting from 30 to 51 min. Control group (CG; n = 8) did not perform any exercises. BWG walked at ∼70%-75%; MTWG at ∼50%-55% of HRR